Green Park’s Advisory Panel consists of a number of thought leaders across industries and sectors who are available to our clients to provide guidance and advice around their diversity agendas. The Panel also feeds in to our Diversity Analytics work and the Green Park Leadership 10,000 and Green Park Public Service Leadership 5,000 reports.
Professor of Economics, University of Bristol
Professor Dame Sandra Dawson
KPMG Professor Emeritus of Management Studies, University of Cambridge
Visiting Professor, Department of Geography, Kings College London
Lecturer in Public Policy at Queen Mary University
Julia Unwin CBE
Chief Executive, Joseph Rowntree Foundation & Joseph Rowntree Housing Trust
Managing Director, Ipsos MORI
Professor Binna Kandola OBE
Senior Partner, Pearn Kandola LLP
Diversity, assessment and development specialist Professor Binna Kandola is a Business Psychologist, Senior Partner and co-founder of Pearn Kandola, where in the last thirty years, he has worked on a wide variety of projects for public and private sector clients both in the UK and overseas.
As well as leading the practice, Binna is particularly interested in the study of gender bias and unconscious bias in organisations. He is the author of two new and critically acclaimed books on these subjects - ‘The Invention of Difference: The story of gender bias at work’ and ‘The Value of Difference: Eliminating bias in organisations’, and the co-author of several other management books, one of which ‘Managing the Mosaic’ won a Special Commendation at the 1994 Management Book of the Year Awards. A regular contributor to the HR and business press he is a sought after and highly regarded conference speaker.
Binna was the first Chair of the Standing Committee for the Promotion of Equal Opportunities of the British Psychological Society (BPS) and a member of Sir Robin Butler’s Panel of Enquiry into Equal Opportunities in the Senior Civil Service. He has been a member of the Board of Trustees of the BPS, and in 2002 was elected as Chair of the Division of Occupational Psychology. In January 2004, Binna was invited to join the UK Government’s National Employment Panel and appointed Chair of the Minority Ethnic Group. He is currently a visiting Professor at Leeds University Business School and at Aston University Business School. In 2012 the University of Aston awarded him an Honorary DSc - Doctor of Science.
He is a consulting editor for the Journal of Occupational and Organisational Psychology and an editorial board member of Development and Learning in Organisations. He is a regular contributor to the media and has appeared on Sky News, BBC Breakfast, Channel 4 News and the Radio 4 Today Show. The Independent on Sunday recognised him in 2004 as one of the UK’s Top Ten Business Psychologists and he is a fellow of the RSA.
Professor Binna Kandola was awarded an OBE in 2008 for his services to Disadvantaged People and Diversity.
Chief Executive Dimension Therapeutics
Dr. Annalisa Jenkins is the chief executive officer of Dimension Therapeutics, a gene therapy company headquartered in Cambridge, MA, developing novel treatments for rare diseases. She brings nearly 20 years of experience in advancing programs across the continuum of scientific research through clinical development and into healthcare systems globally. Prior to joining Dimension, Dr. Jenkins served as executive vice president, head of global research and development for Merck Serono, where she also led global medical affairs and quality. Prior to Merck Serono, Dr. Jenkins held several roles of increasing responsibility at Bristol Myers-Squibb (BMS), most recently serving as senior vice president, global medical affairs. During her tenure at BMS, she made significant contributions to the globalization of medical affairs, the progression and approval of a number of key pipeline programs, and the implementation of BMS’s business development strategy. Earlier in her career, Dr. Jenkins served as a medical officer in the British Royal Navy during the Gulf Conflict in 1991 and subsequently rose to the rank of surgeon lieutenant commander.
Dr. Jenkins serves as chair of the board of Transcelerate Biopharma Inc. and as a member of the boards of directors of Biothera and Prosensa. She also serves on the boards of Women in Bio, the UK Task Force for the Center for Talent Innovation and The Concert Artists Guild of New York. In 2014 Dr Jenkins was named HBA Woman of the Year for her work to support and mentor the next generation of women in science and medicine.
Dr. Jenkins graduated with a degree in medicine from St. Bartholomew’s Hospital in the University of London and subsequently trained in cardiovascular medicine in the UK National Health Service. She is mother to Freddy and Olivia who are both college students in the US.